Physician profile
Georgette Aneed
NPI 1972162931
$1,095.26
in general payments reported to CMS, 2019-2025
11 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.65 · 2022: $350 · 2023: $329 · 2024: $145 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $668.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $557.57 | 2022-2025 | Lifevest |
| Amgen INC. | $81.30 | 2021-2023 | Repatha |
| Chiesi USA, INC. | $75.00 | 2022-2023 | Cleviprex, Kengreal |
| Janssen Pharmaceuticals, INC | $71.29 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $64.71 | 2023-2025 | |
| Pfizer INC. | $52.68 | 2022-2023 | |
| Boston Scientific Corporation | $52.09 | 2024 | Watchman Flx, Varithena Administration Pack |
| Bayer Healthcare Pharmaceuticals INC. | $45.61 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $41.42 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $37.19 | 2022-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $16.40 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georgette Aneed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.